Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
50
Participants
Timeline
Start Date
September 30, 2005
Primary Completion Date
May 31, 2007
Conditions
Lung Cancer
Interventions
BIOLOGICAL
bevacizumab
DRUG
vinorelbine tartrate
Trial Locations (1)
14642-0001
James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester
All Listed Sponsors
lead
University of Rochester
OTHER
NCT00309998 - Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter